Početna › Kolorektalni rak
Kliničke studije za Kolorektalni rak koje traže sudionike u SAD-u
336 studija za Kolorektalni rak traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX102 studija
- New York City, NY77 studija
- Nashville, TN69 studija
- Boston, MA63 studija
- Los Angeles, CA59 studija
- Arlington, VA52 studija
- St. Louis, MO50 studija
- San Antonio, TX46 studija
- Philadelphia, PA44 studija
- Grand Rapids, MI40 studija
- Baldwin Park, CA38 studija
- Seattle, WA34 studija
- Tampa, FL33 studija
- Chicago, IL33 studija
- Dallas, TX33 studija
- Aurora, CO32 studija
- Pittsburgh, PA32 studija
- Queens, NY31 studija
- Baltimore, MD31 studija
- Washington, DC29 studija
- Atlanta, GA29 studija
- Rochester, MN29 studija
- Durham, NC28 studija
- Portland, OR28 studija
- Jacksonville, FL27 studija
- Detroit, MI26 studija
- Phoenix, AZ25 studija
- San Diego, CA25 studija
- Cleveland, OH24 studija
- Columbus, OH24 studija
- Ann Arbor, MI23 studija
- Edison, NJ23 studija
- Santa Monica, CA23 studija
- Denver, CO23 studija
- Madison, WI22 studija
- Oklahoma City, OK22 studija
- Salt Lake City, UT21 studija
- Cincinnati, OH21 studija
- New Haven, CT20 studija
- Minneapolis, MN19 studija
Po državama
- Alabama12 studija
- Aljaska4 studija
- Arizona54 studija
- Arkansas14 studija
- Colorado56 studija
- Connecticut23 studija
- Delaware9 studija
- Distrikt Columbia17 studija
- Florida99 studija
- Georgia38 studija
- Havaji5 studija
- Idaho6 studija
- Illinois51 studija
- Indiana27 studija
- Iowa15 studija
- Kalifornija137 studija
- Kansas19 studija
- Kentucky19 studija
- Louisiana18 studija
- Maine4 studija
- Maryland47 studija
- Massachusetts63 studija
- Michigan72 studija
- Minnesota45 studija
- Mississippi6 studija
- Missouri58 studija
- Montana6 studija
- Nebraska22 studija
- Nevada9 studija
- New Hampshire6 studija
- New Jersey36 studija
- New Mexico8 studija
- New York99 studija
- North Carolina44 studija
- North Dakota7 studija
- Ohio63 studija
- Oklahoma22 studija
- Oregon29 studija
- Pennsylvania69 studija
- Rhode Island5 studija
- South Carolina13 studija
- South Dakota11 studija
- Tennessee76 studija
- Texas145 studija
- Utah36 studija
- Vermont4 studija
- Virginia76 studija
- Washington46 studija
- West Virginia5 studija
- Wisconsin36 studija
- Wyoming3 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT05673148Evaluation for NCI Surgery Branch Clinical Research Protocols
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT00001823Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
U tijeku regrutacija
Od 65 do 82 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05612347A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07525206The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
U tijeku regrutacijaFaza 1
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT04847063A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06265285Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
U tijeku regrutacijaFaza 2
Od 18 do 72 godina · Oba spola · Ažurirano 2. lis 2026. · NCT01174121Family Communications After Genetic Testing
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07143487A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT05176483Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
U tijeku regrutacijaOpažajna studija
Od 2 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT01915225PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
U tijeku regrutacijaFaza 2
Od 18 do 120 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05286814177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07189871Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06625775Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT04751435Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06324357PRE-ISPY Phase I/II Oncology Platform Program
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT05868226A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07085091The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06565052The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07285044Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07551596A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT05877599Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.